| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1017313283 |
| P356 | DOI | 10.1038/GENE.2009.6 |
| P698 | PubMed publication ID | 19262576 |
| P5875 | ResearchGate publication ID | 24178507 |
| P2093 | author name string | C Mohan | |
| H Kanta | |||
| P2860 | cites work | Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein | Q24291950 |
| Dendritic cells and the control of immunity | Q27860918 | ||
| Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis | Q28145757 | ||
| The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling | Q28306258 | ||
| BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor | Q28344730 | ||
| Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA | Q28507714 | ||
| Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells | Q28565650 | ||
| Type I interferons in host defense | Q29615912 | ||
| The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses | Q29616349 | ||
| Predominant autoantibody production by early human B cell precursors | Q29619656 | ||
| Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice | Q33605468 | ||
| Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis | Q33701963 | ||
| Genetic dissection of systemic lupus erythematosus | Q33814991 | ||
| T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells | Q33842929 | ||
| Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies | Q33853007 | ||
| Genetics of systemic autoimmunity in mouse models of lupus | Q34051987 | ||
| The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes | Q34104677 | ||
| Delineating the genetic basis of systemic lupus erythematosus | Q34376876 | ||
| A Tlr7 translocation accelerates systemic autoimmunity in murine lupus | Q34773105 | ||
| The genetics of SLE: an update in the light of genome-wide association studies | Q34793750 | ||
| Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. | Q35795846 | ||
| Genetics of human systemic lupus erythematosus: the emerging picture | Q35931590 | ||
| A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS | Q36267532 | ||
| The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response | Q36365985 | ||
| Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity | Q36370883 | ||
| A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis | Q36398862 | ||
| Defective B cell tolerance checkpoints in systemic lupus erythematosus | Q36402748 | ||
| PTPN22: setting thresholds for autoimmunity | Q36491114 | ||
| Intracellular pattern recognition receptors in the host response | Q36528528 | ||
| Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis | Q36886558 | ||
| Genetics of clinical expression in SLE. | Q37030643 | ||
| Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis | Q37380147 | ||
| Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus | Q37836360 | ||
| Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication | Q38313174 | ||
| Regulation of B cell tolerance by the lupus susceptibility gene Ly108. | Q40267209 | ||
| A y chromosome associated factor in strain bxsb producing accelerated autoimmunity and lymphoproliferation | Q40728079 | ||
| Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain | Q40941667 | ||
| Nephritogenic autoantibodies in lupus: current concepts and continuing controversies | Q40999659 | ||
| Effect of the BXSB Y chromosome accelerating gene on autoantibody production | Q41386762 | ||
| Antibodies to DNA. | Q41756806 | ||
| Familial clustering of end-stage renal disease in blacks with lupus nephritis | Q43532820 | ||
| Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation | Q44899051 | ||
| Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus | Q45180946 | ||
| Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus | Q46604389 | ||
| The familial risk of end-stage renal disease in African Americans | Q46726027 | ||
| Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease | Q46789333 | ||
| The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). | Q46919587 | ||
| The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. | Q51024901 | ||
| Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval. | Q51760370 | ||
| Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. | Q51835981 | ||
| Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. | Q52012264 | ||
| Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. | Q52085933 | ||
| Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. | Q52529090 | ||
| Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. | Q53592228 | ||
| Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. | Q53679155 | ||
| Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
| Polygenic control of susceptibility to murine systemic lupus erythematosus | Q57903408 | ||
| The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice | Q68094972 | ||
| PD-1: an inhibitory immunoreceptor involved in peripheral tolerance | Q73807451 | ||
| A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus | Q74500174 | ||
| Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus | Q74540694 | ||
| Genetic susceptibility to systemic lupus erythematosus | Q74578130 | ||
| Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells | Q74817353 | ||
| Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice | Q77341412 | ||
| Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis | Q77394400 | ||
| Epistatic modifiers of autoimmunity in a murine model of lupus nephritis | Q78257965 | ||
| Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c | Q80345175 | ||
| CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis | Q80974221 | ||
| Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing | Q81111426 | ||
| Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis | Q83276319 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 390-396 | |
| P577 | publication date | 2009-03-05 | |
| P1433 | published in | Genes and Immunity | Q15745246 |
| P1476 | title | Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation | |
| P478 | volume | 10 |
| Q35102250 | A novel isoform of the Ly108 gene ameliorates murine lupus. |
| Q37976347 | A novel pathogenetic concept-antiviral immunity in lupus nephritis. |
| Q37281149 | Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies |
| Q28071491 | Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review |
| Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
| Q36453064 | Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells |
| Q28394057 | Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease |
| Q37541225 | Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. |
| Q37158607 | IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. |
| Q35142708 | IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production |
| Q38176819 | Immunopathology of lupus nephritis |
| Q50485658 | Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis. |
| Q34163340 | Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity |
| Q33920964 | Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus |
| Q35867038 | Lupus nephritis: an overview of recent findings |
| Q22000837 | Lupus nephritis: current update |
| Q42330845 | Protection against lupus-like inflammatory disease is in the LAP of non-canonical autophagy |
| Q33644106 | Systemic lupus erythematosus diagnostics in the 'omics' era |
| Q37995556 | TLR7 and TLR9 in SLE: when sensing self goes wrong |
| Q36565949 | The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study |
| Q58102052 | The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients |
| Q59127682 | Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 Mice |
| Q34650870 | Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment. |
| Q36504624 | Treatment targets in systemic lupus erythematosus: biology and clinical perspective |
| Q37713730 | Type I interferon therapy and its role in autoimmunity |
| Q33877996 | Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. |
| Q35854962 | Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production |
Search more.